Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: The case of previous abdominal surgery. Results from a prospective trial
Creators
- 1. Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (Italy)
- 2. Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (Italy)
- 3. Radiotherapy and Medical Physics, Ospedale di Circolo, Varese (Italy)
- 4. Radiotherapy and Medical Physics, Ospedale Santa Chiara, Trento (Italy)
- 5. Department of Radiotherapy and Medical Physics, Ospedale Villa Maria Cecilia, Lugo (Italy)
- 6. Department of Radiotherapy and Medical Physics, Ospedale Sant'Anna, Como (Italy)
- 7. Department of Radiotherapy and Medical Physics, Institute for Cancer Research and Treatment, Candiolo (Italy)
- 8. Medical Physics, Ospedale San Raffaele, Istituto Scientifico San Raffaele, Milano (Italy)
Description
Purpose: To evaluate and discuss the role of specific types of abdominal surgery (SURG) before radical radiation therapy as a risk factor for late rectal toxicity in prostate cancer patients. Methods: Results concerning questionnaire-based scored late bleeding and faecal incontinence in 718 patients with a complete follow-up of 36 months were analysed, focusing on the impact of specific pre-radiotherapy abdominal/pelvic surgery procedures. Patients were accrued in the prospective study AIROPROS 0102. Different types of surgery (rectum-sigma resection, kidney resection, cholecystectomy or appendectomy) were considered as covariates together with a number of different parameters previously found to be predictive of late toxicity and including clinical as well as dosimetric parameters. Univariate (UVA) and multivariate (MVA) logistic analyses were carried out. Results: In total 69/718 patients were previously submitted to one or more surgical procedures, mostly cholecystectomy (n = 21) and appendectomy (n = 27). Actuarial incidences of G2–G3 and G3 bleeding were 52 (7.2%) and 24 (3.3%) respectively; 19 (2.6%) chronic incontinence events were registered. Cholecystectomy was found to be highly correlated with late rectal bleeding at UVA: OR = 4.3 and p = 0.006 for G2–G3 and OR = 5.4 and p = 0.01 for G3. Considering MVA (including dosimetric and clinical factors), G2–G3 bleeding was significantly correlated to cholecystectomy (OR = 6.5, p = 0.002), V75Gy (OR = 1.074, p = 0.003) and secondarily with appendectomy (OR = 2.7, p = 0.10), presence of acute radioinduced rectal bleeding (OR = 1.70, p = 0.21) and androgen deprivation (OR = 0.67, p = 0.25). Appendectomy (OR = 5.9, p = 0.004) and cholecystectomy (OR = 5.5, p = 0.016) were very strong predictors of G3 bleeding with V75Gy playing a less significant role (OR = 1.037, p = 0.26). Conversely, no specific surgery was correlated with actuarial or chronic incontinence. Conclusions: This analysis highlights previous SURG as the best predictor of late rectal bleeding. Among the different types of abdominal surgery, cholecystectomy and appendectomy play the major role, especially for severe late bleeding.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.radonc.2012.03.012Additional details
Identifiers
- DOI
- 10.1016/j.radonc.2012.03.012;
- PII
- S0167-8140(12)00146-6;
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 103
- Journal Issue
- 2
- Journal Page Range
- p. 252-255
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 44102102
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANDROGENS; HEALTH HAZARDS; KIDNEYS; MULTIVARIATE ANALYSIS; NEOPLASMS; PATIENTS; PROSTATE; RADIATION DOSES; RADIOTHERAPY; RECTUM; SURGERY; TOXICITY
- Descriptors DEC
- ANDROSTANES; BODY; DIGESTIVE SYSTEM; DISEASES; DOSES; GASTROINTESTINAL TRACT; GLANDS; HAZARDS; HORMONES; INTESTINES; LARGE INTESTINE; MALE GENITALS; MATHEMATICS; MEDICINE; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANS; RADIOLOGY; STATISTICS; STEROID HORMONES; STEROIDS; THERAPY
Optional Information
- Copyright
- Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.